These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 6271678

  • 21. Pseudomonas aeruginosa exoenzyme S ADP-ribosylates Ras at multiple sites.
    Ganesan AK, Frank DW, Misra RP, Schmidt G, Barbieri JT.
    J Biol Chem; 1998 Mar 27; 273(13):7332-7. PubMed ID: 9516428
    [Abstract] [Full Text] [Related]

  • 22. The role of exoenzyme S in infections with Pseudomonas aeruginosa.
    Nicas TI, Bradley J, Lochner JE, Iglewski BH.
    J Infect Dis; 1985 Oct 27; 152(4):716-21. PubMed ID: 2995500
    [Abstract] [Full Text] [Related]

  • 23. Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury.
    Kudoh I, Wiener-Kronish JP, Hashimoto S, Pittet JF, Frank D.
    Am J Physiol; 1994 Nov 27; 267(5 Pt 1):L551-6. PubMed ID: 7977765
    [Abstract] [Full Text] [Related]

  • 24. Use of transposon mutants to assess the role of exoenzyme S in chronic pulmonary disease due to Pseudomonas aeruginosa.
    Woods DE, Sokol PA.
    Eur J Clin Microbiol; 1985 Apr 27; 4(2):163-9. PubMed ID: 2988944
    [Abstract] [Full Text] [Related]

  • 25. Highly frequent single amino acid substitution in mammalian elongation factor 2 (EF-2) results in expression of resistance to EF-2-ADP-ribosylating toxins.
    Kohno K, Uchida T.
    J Biol Chem; 1987 Sep 05; 262(25):12298-305. PubMed ID: 2887567
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of Pseudomonas aeruginosa exoenzyme expression by subinhibitory antibiotic concentrations.
    Grimwood K, To M, Rabin HR, Woods DE.
    Antimicrob Agents Chemother; 1989 Jan 05; 33(1):41-7. PubMed ID: 2496657
    [Abstract] [Full Text] [Related]

  • 27. Characterization of the endogenous ADP-ribosylation of wild-type and mutant elongation factor 2 in eukaryotic cells.
    Fendrick JL, Iglewski WJ, Moehring JM, Moehring TJ.
    Eur J Biochem; 1992 Apr 01; 205(1):25-31. PubMed ID: 1313365
    [Abstract] [Full Text] [Related]

  • 28. Analysis of Pseudomonas aeruginosa clinical isolates for possible variations within the virulence genes exotoxin A and exoenzyme S.
    Rumbaugh KP, Hamood AN, Griswold JA.
    J Surg Res; 1999 Mar 01; 82(1):95-105. PubMed ID: 10068532
    [Abstract] [Full Text] [Related]

  • 29. Use of synthetic peptides and site-specific antibodies to localize a diphtheria toxin sequence associated with ADP-ribosyltransferase activity.
    Olson JC.
    J Bacteriol; 1993 Feb 01; 175(3):898-901. PubMed ID: 8423159
    [Abstract] [Full Text] [Related]

  • 30. ADP-ribosylating toxins.
    Passador L, Iglewski W.
    Methods Enzymol; 1994 Feb 01; 235():617-31. PubMed ID: 8057931
    [No Abstract] [Full Text] [Related]

  • 31. Auto-ADP-ribosylation of Pseudomonas aeruginosa ExoS.
    Riese MJ, Goehring UM, Ehrmantraut ME, Moss J, Barbieri JT, Aktories K, Schmidt G.
    J Biol Chem; 2002 Apr 05; 277(14):12082-8. PubMed ID: 11821389
    [Abstract] [Full Text] [Related]

  • 32. Exoenzyme S from P. aeruginosa ADP ribosylates rab4 and inhibits transferrin recycling in SLO-permeabilized reticulocytes.
    Bette-Bobillo P, Giro P, Sainte-Marie J, Vidal M.
    Biochem Biophys Res Commun; 1998 Mar 17; 244(2):336-41. PubMed ID: 9514923
    [Abstract] [Full Text] [Related]

  • 33. The frequency of genes encoding exotoxin A and exoenzyme S in Pseudomonas aeruginosa strains isolated from burn patients.
    Khosravi AD, Shafie F, Abbasi Montazeri E, Rostami S.
    Burns; 2016 Aug 17; 42(5):1116-1120. PubMed ID: 27263417
    [Abstract] [Full Text] [Related]

  • 34. Combined treatment with Pseudomonas aeruginosa toxin and interferon on mouse and human cells.
    Salzberg S, Parizade P, Nitzan Y.
    Toxicon; 1989 Aug 17; 27(8):917-26. PubMed ID: 2476872
    [Abstract] [Full Text] [Related]

  • 35. Pseudomonas aeruginosa cystic fibrosis clinical isolates produce exotoxin A with altered ADP-ribosyltransferase activity and cytotoxicity.
    Gallant CV, Raivio TL, Olson JC, Woods DE, Storey DG.
    Microbiology (Reading); 2000 Aug 17; 146 ( Pt 8)():1891-1899. PubMed ID: 10931893
    [Abstract] [Full Text] [Related]

  • 36. Proteolytic cleavage of exotoxin A from Pseudomonas aeruginosa: formation of an ADP-ribosyltransferase active fragment by the action of Pseudomonas elastase.
    Sanai Y, Morihara K, Tsuzuki H, Homma JY, Kato I.
    FEBS Lett; 1980 Oct 20; 120(1):131-4. PubMed ID: 6254804
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The role of exotoxin A in pseudomonas disease and immunity.
    Pollack M.
    Rev Infect Dis; 1983 Oct 20; 5 Suppl 5():S979-84. PubMed ID: 6419320
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.